Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Sankyo patent describes novel IL-4 and/or IL-10 production promoters

Nov. 21, 2003

Novel glucocorticoid receptor modulators covered by Merck patent

Nov. 20, 2003

Celltech researchers describe new IMPDH inhibitors in a recent patent

Nov. 20, 2003

Boehringer and TeGenero partner for production of CD28-SuperMAB

Nov. 19, 2003

Kyowa Hakko and Millennium present new chemokine CXCR3 modulators

Nov. 19, 2003

Japanese team identifies compounds with leukocyte-enhancing and DPP-IV-inhibitory activity

Nov. 13, 2003

Phase I trial begins for ChimeriVax-West Nile vaccine

Nov. 10, 2003

Novartis patent covers new inhibitors of PKC and IL-2 production

Nov. 6, 2003

CP-690550 prevents organ transplant rejection in monkeys

Nov. 6, 2003

Genzyme and MacroGenics collaborate on therapies for immune-mediated disease

Nov. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...